The objectives of this article were to review the causes and extent of hospital-associated infectious diarrhea and associated risks in the general hospital ward and intensive care unit (ICU), to compare microorganisms with similar symptoms to aid in recognition that will lead to timely and appropriate treatment and control measures, and to propose infection prevention protocols that could decrease human process errors in the ICU. This literature review describes epidemiology, comparison of microbial characteristics for potential hospital-associated enteric pathogens, diagnosis, and prevention, especially if important in the ICU, and particularly in regard to Clostridium difficile. Enteric organisms that most commonly cause hospital-associated infectious diarrhea in acute care settings and the ICU are C. difficile, rotavirus, and norovirus, although others may also be important, particularly in developing countries. To recognize and control infectious diarrhea successfully in the ICU, intensivists should be aware that epidemiology, risks, and prevention measures may differ between these microorganisms. In addition, intensivists should be ready to implement systems changes related to notification, isolation precautions and prevention, and environmental cleaning in the ICU. (Crit Care Med 2010; 38[Suppl.]:S324 -S334)
P atients are at increased risk for developing diarrhea in the hospital, with as many as 40% to 90% of some intensive care unit (ICU) patient populations affected (1, 2) . Diarrhea adversely impacts critically ill patients by contributing to dehydration, electrolyte imbalances, hemodynamic instability, malnutrition, and skin breakdown. The etiologies of most cases of diarrhea are noninfectious and include enteral feeding, fecal impaction, bacterial overgrowth, medications, psychological stress, diagnostic test reagents, certain tumors, endocrine disorders, malabsorption, hypoalbuminemia, intestinal ischemia, or exacerbations of inflammatory bowel disease (3) . Infectious causes of diarrhea in the ICU are less common than noninfectious causes but are a major concern. Infectious diarrhea is typically more severe than noninfectious diarrhea, increasing the likelihood of developing complications, such as arrhythmias due to electrolyte abnormalities, cardiopulmonary instability requiring vasopressors and mechanical ventilation, or intraabdominal catastrophes. Infectious diarrhea in the healthcare setting can also be more problematic than noninfectious causes because the causative agent often can be transmitted from patient to patient, from patient to healthcare worker, or vice versa. Hospital-associated infectious diarrhea accounted for 21% of all 223 healthcare-related outbreaks reported to the Centers for Disease Control and Prevention from 1956 to 1979 (4) . The most common cause of infectious diarrhea in the ICU is Clostridium difficile, a pathogen associated with increasing prevalence and severity of infection. Salmonella, rotavirus, and norovirus have also been associated with outbreaks in healthcare facilities, including the ICU (Table 1 ).
Recognition and Diagnosis of Infectious Diarrhea in the ICU
It is essential to consider an infectious etiology in an ICU patient with diarrhea, especially if the patient has Ͼ3 bowel movements per day, blood or mucus in the stool, vomiting, severe abdominal pain, and/or fever ( Table 2) . Establishing the diagnosis is important not only to initiate specific treatment for the patient with diarrhea but also to implement measures to prevent the spread of the causative organism to other patients and staff in the ICU. Person-to-person spread is the most common form of transmission, and C. difficile is the most common causative pathogen of healthcare-associated enteric infection outbreaks. However, it is important to keep in mind that intestinal pathogens of interest in the United States are still present in the food supply and that contaminated food has been implicated as a vehicle in some hospitalassociated enteric infection outbreaks. The U.S. preliminary surveillance Food-Net data from the Communicable Disease Center indicates that none of the Healthy People 2010 targets for reduction of foodborne pathogens has been met as of 2008 (14) . Enteric pathogens in this report included Campylobacter, Listeria, Salmonella, Shigella, Shiga toxin-producing Escherichia coli O157, Yersinia, and Cryptosporidium. In addition, rotavirus and norovirus, typically considered causes of gastroenteritis in the community, are the most common etiologies of hospital-associated diarrhea in children (15) (16) (17) (18) . Hospital-associated outbreaks due to these pathogens also have occurred in adults (15) (16) (17) (18) . Persons aged Ն50 yrs, the very young, and immuno-compromised patients who develop diarrhea with these pathogens are at greatest risk for hospitalization, infection, and ultimately death. Several of these organisms can be shed postinfection, have a carrier state, or have cysts that are resistant to most disinfectants. Hospital outbreaks through patient-to-patient or healthcare worker-to-patient transmission and contamination of food in the hospital have occurred.
If the index of suspicion is high enough to warrant testing for an intestinal pathogen, there are a wide number of potential causative pathogens, and no single test is able to detect all of them. Table 2 contains enteric bacteria, viruses, and parasites that have been or could potentially be involved in hospitalassociated diarrhea in developed and developing countries. Although these or-ganisms share diarrhea as a common element, they may differ markedly in mode of transmission, incubation period, and duration of illness. In addition, seasonal outbreaks are part of the infection cycle in some, and attention to temporality can aid in preliminary identification of the pathogen.
Reliable and accurate laboratory diagnostic tests are critical for identification that cannot be made by the clinical presentation of the diarrheal illness alone. In some cases, insensitive or nonspecific characteristics of the test assay have delayed correct treatment and resulted in incorrect control measures and economic loss (19 -22) . In addition, spatial characterization of an outbreak can be examined using strain typing, and this can be important in determining whether strains are endemic or epidemic for con-trol measures. However, typing is not readily available in most clinical laboratories in developed countries and in resource-poor areas. There is usually a delay in generating this information for infection control in developed regions due to the need for reference laboratories with highly trained personnel to perform specialized techniques.
A modified "3-day rule" has been proposed to aid in when to culture stool for enteropathogenic bacteria other than C. difficile (23, 24). This "rule" is a safe and cost-effective cutoff for rejecting stool samples of adult patients due to low yield of enteric pathogenic bacteria detected in patients hospitalized for at least 3 days (Ͻ1%), as compared with the yield if the specimen was collected within 3 days (2.6% to 6.4%). The same conclusion was obtained when children were included in a similarly designed study (25). This rule allows the laboratory to discard the stool sample if the patient has been in the hospital Ͼ3days, unless there are exceptions. Proposed exceptions to the "3-day rule" rule were neutropenia (Ͻ0.5 ϫ 10 6 cells/mL), human immunodeficiency virus (HIV) infection, suspected nondiarrheal manifestation of enteric infection (erythema nodosum, mesenteric lymphadenitis, polyarthritis, fever of unknown origin), patient age of Ͼ65 yrs with comorbidities causing end-organ damage, or a suspected hospital-acquired outbreak (26). Good communication between the ICU and the laboratory should be maintained, as some of these organisms may have a latency period and others may have a prolonged incubation time. There have been no formal studies on ICU patients in regard to a "3-day rule."
Epidemiologic and Microbial Characteristics That Are Important for Prevention and Control
Bacteria C. difficile. C. difficile is an anaerobic, spore-forming bacillus that produces two exotoxins, toxin A and toxin B. These toxins cause intestinal pathology by disruption of the actin cytoskeleton and induction of neutrophil migration and mucosal inflammatory cascades (27-29). This organism was first reported in the stools of healthy infants in 1935 (30). C. difficile was relatively unnoticed for the next four decades, until Tedesco et al (31) recognized the association of clindamycin with colitis in 1974. Shortly thereafter, Bartlett and colleagues identified C. difficile as the major cause of antibiotic-associated colitis and the primary causative agent of pseudomembranous colitis (32).
In adults, C. difficile is now the leading cause of infectious hospital-associated diarrhea in the United States, Canada, and Europe, and it is being recognized increasingly in other parts of the world (33, 34). Because C. difficile infection (CDI) is not yet a reportable disease in the United States as in the United Kingdom and some European countries, the true burden on health and healthcare spending, including the ICU, is not really known (35).
National estimates indicate that the frequency of CDI increased from 5.5 cases per 10,000 population in adults (Ͼ17 yrs old) discharged from hospitals in the year 2000 to 11.2 cases per 10,000 in the year 2005 (36, 37). This represents a 23% average crude increase annually from 2000 to 2005, which contributed to 1.3% increase in overall hospitalizations (36). Data from acute care, ICU, and cancer, cardiac, children's, long-term, and rehabilitation hospitals were collected on 1 day between May and August 2008 for 1,443 patients with CDI from 648 hospitals (12.5% of all medical facilities) (38). The point prevalence of CDI was 13 of 1,000 patients either infected or colonized. This was extrapolated to 7,178 affected inpatients on any given day. Overall 30-day mortality in patients with CDI in the ICU was almost 40% during 2004 to 2005, and 6% mortality was directly attributable to CDI in the ICU (39, 40).
A constellation of interacting variables might explain the increased prevalence and severity of CDI. These include clonal expansion of the hypervirulent BI/NAP1/ 027 epidemic strain of C. difficile, lack of timely recognition of severe CDI, changes in medication-prescribing practices, and increased and more complex patient comorbidities in an increasingly aging or immunocompromised population (41-46). The BI/NAP1/027 clone has recently been implicated in several large outbreaks, with an associated increase in CDI severity (44, 45, 47, 48). Increased virulence of BI/NAP1/027 is thought to be due to its ability to produce 16 -23 times more toxin A and toxin B, respectively. This strain also produces "binary toxin," and this may also contribute to increased CDI severity (44, 49, 50).
C. difficile can cause a range of syndromes from asymptomatic colonization to a mild self-limited diarrhea, to a lifethreatening colitis. Fatal ileitis in the absence of colonic involvement with C. difficile has also been recently described (51). Common symptoms of CDI include a watery, foul-smelling diarrhea, nausea, mild abdominal pain or cramping, and fever. CDI can progress rapidly to fulminant colitis with systemic inflammatory response syndrome and shock, resulting in death within hours or weeks. Although diarrhea is considered the hallmark for symptomatic CDI, abdominal pain and lack of diarrhea could indicate ileus with toxic megacolon. It is important to recognize many patients in the ICU have risk factors associated with severe CDI, such as advanced age, immunosuppression, and hypoalbuminemia, because data (42, 52, 53) indicated that oral vancomycin is superior to metronidazole for treating severe CDI. To date, there is not a validated set of markers, either clinical or biological, that can be used to predict morbidity and mortality.
Independent risk factors for CDI include exposure to antimicrobials, age of Ͼ60 yrs, exposure to other patients with CDI, residence in a chronic care facility, gastric acid suppression, and severe underlying disease (54 -56). Other important risk factors for CDI seen in the ICU include recent surgery, immunosuppression, and a newly recognized risk, pregnancy (57, 58). It can be difficult to identify patients at risk for CDI in the ICU because many patients in the ICU have the risk factors listed above.
Antimicrobial exposures are the most common and potentially modifiable risk factor for CDI in the ICU setting. Antimicrobials increase the risk for CDI by altering protective gut flora. Historically, clindamycin, ampicillin, and cephalosporins were the antimicrobials associated with the greatest risk for CDI (59). More recently, fluoroquinolones have emerged as another antimicrobial strongly associated with CDI (60). Prolonged courses of antibiotics and the exposure to multiple antibiotics are also associated with CDI (60).
CDI has also been associated with gastric acid suppressive agents, such as H 2 receptor antagonists and proton pump inhibitors (55, 56). These medications are almost universally used in the ICU to help reduce the risk of stress-associated mucosal damage (61). Clostridial spores survive at gastric pH 1, but gastric acid may inhibit the germination of spores into vegetative, toxin-producing cells. This may explain the increased risk of CDI associated with gastric acid suppression (62). In addition, CDI is associated with tube feeds and in particular postpyloric tube feeds (63-66). This provides additional evidence that gastric acid, despite not killing C. difficile spores, may be important in the prevention of CDI.
C. difficile testing is recommended for adults and children Ն1 yr old with unexplained diarrhea associated with antibiotic use. There are several laboratorybased methods to diagnose CDI, and they all have advantages and disadvantages. Most commonly employed are tests to detect toxin A and/or B from the stool of a patient with diarrhea. The cell culture cytotoxicity assay is the most sensitive method to detect toxin from stool. However, it takes 24 -72 hrs for results, it requires the ability to maintain cell cultures, and it is relatively expensive. The most common method to diagnose CDI in the United States is with enzyme immunoassays to detect both toxins. These tests are rapid with same-day results and are inexpensive. The disadvantage of these assays is they are less sensitive than most other laboratory-based assays to diagnose CDI.
Other tests that detect C. difficile in the stool include stool culture for C. difficile, enzyme immunoassays that detect glutamate dehydrogenase, and polymerase chain reaction-based tests. Stool culture for C. difficile is the most sensitive method for detecting C. difficile in the stool, but it is expensive, labor intensive, and takes 48 -96 hrs for results. Enzyme immunoassays that detect glutamate dehydrogenase are highly sensitive, but they are not specific. Some facilities use a glutamate dehydrogenase enzyme immunoassays as a screen and confirm positives with a cell culture cytotoxicity assay (67) . Polymerase chain reaction-based assays seem highly sensitive and specific, but they are expensive and require specialized equipment (68) .
There are two primary approaches for preventing CDI: preventing transmission and exposure to C. difficile, and decreasing risk of infection if exposure to C. difficile occurs. Recommendations for preventing CDI in acute care facilities have been published recently (69) . Included in the published recommendations are methods to facilitate diagnosis and implementation of prevention measures. These will be covered in the "Prevention and Control Measures" section, as they are pertinent for all infectious, transmissible causes of diarrhea in the healthcare setting.
The main mechanism of C. difficile spread is via fecal-oral transmission of the spores from person to person. The infectious dose 50 is not known in humans, but humans with CDI are reported to excrete 10 7 -10 9 spores/g of feces, and Ͻ10 spores are able to cause disease in hamsters (70, 71) . Healthcare workers, including physicians, spread the spores on their hands or on medical equipment, and spores can be isolated from the environment weeks or months after discharge of an infected person (72, 73) . Basic measures to prevent transmission of CDI in the healthcare setting include conducting CDI surveillance, placing patients with CDI in contact precautions, and monitoring of hand hygiene, contact precaution, and environmental cleaning practices compliance.
Although C. difficile spores are resistant to alcohol and standard hospital dis-infectants used to clean patient rooms, it is not recommended to routinely avoid alcohol-based hand hygiene products after caring for a patient with CDI or to routinely use diluted bleach or other agents with activity against spores for environmental cleaning. Several studies (74 -81) have failed to demonstrate an increase in CDI with the use of alcoholbased hand hygiene products, and sporicidal environmental disinfectants can be difficult to use and have not been consistently associated with a reduction in CDI. However, it is recommended to consider preferentially washing hands with soap and water rather than using alcoholbased hand hygiene products and to use bleach for environmental cleaning in outbreak settings if compliance with hand hygiene, contact precautions, and environmental disinfection are otherwise considered adequate.
Decreasing the risk of CDI if C. difficile transmission occurs involves antimicrobial stewardship. The first line of defense against developing CDI after C. difficile exposure is healthy gut flora. Antimicrobial stewardship, by decreasing the number of patients on antimicrobials and/or decreasing high-risk antimicrobial exposures, decreases the number of patients at risk for CDI if C. difficile exposure occurs. This, in turn, will also decrease C. difficile transmission by decreasing the number of patients with CDI contributing to the spread of C. difficile. Antimicrobial stewardship programs focused on restriction of a single antimicrobial and programs focused on improving antimicrobial prescribing practices have led to reductions in CDI, including an outbreak due to the NAP1 strain (82) (83) (84) .
Salmonella enterica. Salmonella enterica is a facultative intracellular Gramnegative enteric bacillus, whose species contains Ͼ2500 serotypes. Most human infections worldwide are caused by S. enterica subsp. enterica serotypes Typhi, Typhimurium, and Cholerasuis, and S. enteritidis causes most of the foodborne illnesses in the United States (85, 86) . The infectious dose 50 for nontyphoidal disease varies from 200 to 1 million bacilli (87) . Salmonella Typhi is more apt than nontyphoidal Salmonella in causing bacteremia and invasive disease.
Worldwide estimates of nontyphoidal Salmonella infection are from 200 million to 1.3 billion, with 3 million deaths annually (88) . An estimated 1.4 million people in the United States are infected with nontyphoidal Salmonella annually (14) . The reported 2007 incidence was 14.9 cases per 100,000, and this has been stable since 2004. Reservoirs for Salmonella include humans, poultry, swine, reptiles, dogs, and cats. Fecal-oral transmission occurs by way of water, eggs, dairy, and other products, with unpasteurized orange juice recently recognized as a vehicle (86, 89) . Typically thought of as a community pathogen, Salmonella frequently causes disease in the healthcare setting. Although Salmonella is typically associated with contaminated food, secondary transmission can occur in the healthcare setting by direct person-toperson spread or indirectly from contaminated fomites (such as endoscopes). Up to 35% of cases of Salmonella in the United States are healthcare associated; Salmonella caused Ͼ50% of outbreaks in nursing homes between 1975 and 1987 and 81% of nursing home deaths from foodborne illness (case fatality rate of 3.8%) (90) .
Ages of Ͻ20 yrs and Ͼ70 yrs are associated with an increased risk of infection due to Salmonella. Neonates are at the greatest risk for infection after exposure due to relatively decreased stomach acid, and the elderly due to comorbidities. In addition, immunocompromised states due to HIV, chemotherapy, or aplastic anemia also are recognized as increasing risk of salmonellosis (85, 91, 92) .
Salmonellosis can present with acute gastroenteritis, enteric fever, bacteremia, extraintestinal infection, or as an asymptomatic, chronic carrier state. There can be fairly significant abdominal pain that is similar to that of inflammatory bowel disease or pseudoappendicitis (87) . Gastroenteritis is highest during May through October in temperate climates. Antibiotics are usually not indicated because gastroenteritis is self-limited in otherwise healthy people. The exceptions are moderate or severe disease, the presence of bacteremia, sickle cell disease or prosthetic grafts, extraintestinal disease, and disease in immunocompromised hosts (85, 87, 93) .
Stool culture is the mainstay of diagnosis, but sensitivity decreases after the first week of illness or with antibiotic therapy. Blood cultures are indicated with persistent fever or signs of sepsis. Salmonella is a reportable disease, and local reporting requirements should be followed. To characterize an outbreak, highly discriminative nucleic acid typing methods of the serovar can be done (94) .
A single case of Salmonella infection should prompt an investigation as to whether the infection is healthcare associated. Many healthcare-associated outbreaks of Salmonella start with contaminated food. Outbreak investigations should evaluate food-handling practices as well as potential patient-to-patient and healthcare worker-to-patient transmission. Because the hospital case/outbreak could be part of a larger epidemic, it is important that the ICU works closely with infectious diseases specialists, infection prevention and control personnel, and public health officials. Standard hospital disinfectants and alcohol-based hand hygiene products are effective against Salmonella species. Contact precautions are reserved for incontinent or diapered patients to control institutional outbreaks.
Viruses
Rotavirus. Rotavirus is nonenveloped virus with a double-stranded, segmented ribonucleic acid genome. Rotavirus is found worldwide and infects almost all children by 2-3 yrs of age (95) . The prevalence of gastroenteritis due to rotavirus is the same in developed and developing countries, but mortality is higher in impoverished regions with malnutrition and poor access to medical care (96) .
Transmission is primarily by the fecaloral route, and dry conditions in the winter may help facilitate spread (97, 98) . According to the literature (16, 17, 99, 100) , 91% to 94% of hospital-acquired infectious diarrhea cases in children are due to viruses, including the ICU, and rotavirus causes 31% to 87% of these cases. Rotavirus is excreted from affected infants at 10 8 -10 11 virions/g feces and can occur before symptoms, with prolonged shedding during convalescence. Spread of rotavirus among neonatal ICU infants from the hands of healthcare workers and visitors, with subsequent transmission to the regular ward, has occurred (100). In the United States, rotavirus hospital-acquired diarrhea alone increased hospitalization cost from $500 -$2,500 per case, but the total economic burden is not yet known (101) .
The primary risk factor for rotavirus is exposure of a nonimmune person to a person with symptomatic infection. Immunity after an initial episode is incomplete, but subsequent episodes of illness are less severe. The incubation period for rotavirus is typically around 2 days and symptoms can last 3-8 days. Profuse watery diarrhea with dehydration and electrolyte abnormalities is generally more severe in infants and children with rotavirus infection than with diarrhea caused by other common enteric pathogens (102) (103) (104) . Vomiting is more common and prolonged with rotavirus compared with other pathogens as well. In immunocompromised children, rotavirus can be associated with chronic diarrhea, prolonged shedding, and extraintestinal infection (105) . Rotavirus has caused severe infections in adults, including some deaths (18) .
Because it is difficult to distinguish gastroenteritis due to rotavirus from other causes of gastroenteritis on clinical grounds alone, confirmation of the diagnosis is important for complicated cases, in immunocompromised patients, and for epidemiologic infection control purposes. Rotavirus detection is possible by many assays, but enzyme-linked immunoassays for VP2 and VP6 are widely used (106) . Reverse-transcriptase polymerase chain reaction on stool samples is more sensitive than enzyme-linked immunoassays for rotavirus and is now the major diagnostic test. Some of these tests have the ability for fine type discrimination of P and G types for epidemiologic studies (107, 108) .
All patients with rotavirus infection should be placed on contact precautions for the duration of their illness. Rotavirus is very hardy and resists inactivation by chlorination found in sewage effluents and drinking water (98, 109) . However, it is inactivated by antiseptics with Ͼ40% alcohols, free chlorine Ͼ20,000 ppm, Ͼ10,000 ppm iodine, phenol-based compounds, and calcium chelators (110) . A commercial disinfectant spray with 79% ethanol and 0.1% o-phenylphenol (Lysol) prevented transmission from fomites to human volunteers, and quaternary ammonium products were found to be no more effective than tap water (111) . Rotavirus survival decreases markedly with high humidity.
Norovirus. Norovirus is a singlestranded positive-sense ribonucleic acid virus that is a member of the Calicivirus group. It is found worldwide and causes an estimated 23 million cases in the United States annually (112, 113) . Norovirus gastroenteritis comprises 17% to 46% of viral, hospital-associated gastroenteritis in children (114 -116) . Sero-prevalence studies (117) indicated norovirus exposure occurs in early childhood, and 90% of older children and adults have been exposed.
Norovirus hospital-associated outbreaks have occurred both in pediatric and adult patients on the general wards and in the ICU ( Table 1 ). The major mode of transmission is person to person by fecal or vomitus-oral route (114, 115) . Rapid secondary spread from patients to healthcare workers, low infectious dose, very short incubation time, and survival in feces and vomitus necessitate rapid recognition of norovirus for implementation of control measures and to prevent patient morbidity and economic loss (116) . In one large outbreak involving a coronary care unit and psychiatric wards, the high attack rate for patients and healthcare workers resulted in unit closures, extensive disinfection, and furloughing or cohorting staff and cost an estimated $658,000 (19) .
There are also cases of norovirus pseudo-outbreaks and norovirus outbreaks being mistakenly attributed to other pathogens. In several neonatal ICU outbreaks in Europe, false-positive results from different manufacturers of norovirus antigen enzyme immunoassays resulted in implementation of prevention measures that were costly and unnecessary. A rapidly disseminating outbreak that was originally attributed to C. difficile but was really due to norovirus occurred in a hospital where C. difficile was endemic (118) . Conversely, efforts to abort a norovirus outbreak resulted in a reduction in CDI (20 -22, 119) .
The primary risk factor for norovirus is exposure of a nonimmune patient to a patient shedding norovirus. Immunity to norovirus seems to be strain specific and wanes after several months. The incubation period is 24 -48 hrs but can be as short as 12 hrs. In general, abdominal cramping and/or nausea can occur gradually or abruptly, followed by vomiting and/or diarrhea. Fever up to 101°-102°F can occur, and diarrhea, although it can be profuse, typically lasts only 24 -60 hrs ( Table 2) .
Specific diagnosis requires laboratory confirmation because the signs and symptoms of norovirus gastroenteritis are not characteristic. Unfortunately, testing for norovirus is not routinely performed in clinical laboratories in the United States. Sensitive and specific antigen enzyme immunoassays on stool are valid for detection as long as the mono-clonal antibody panel can detect antigenic variants of the capsid protein (120, 121) . Highly sensitive reverse-transcriptase polymerase chain reaction is also useful for detecting and genotyping norovirus in stool, food, and environmental samples (122) . Immunoassays have been used for diagnosis of antibody to the virus, with titer increase within 10 -14 days of onset (123, 124) . Serology can be useful, because diarrhea is generally short-lived and limits the time available to collect samples for characterizing outbreaks.
It is extremely important that intensivists recognize norovirus gastroenteritis early, due to the debilitating nature of the disease, the explosiveness of outbreaks, and the high infectivity and stability of the virus (19) . Patients who are incontinent or diapered should remain in contact precautions for the duration of their illness. Special attention needs to be paid to environmental cleaning, even if surfaces do not seem to be soiled. It may be necessary to clean the environment with bleach (500 ppm available chlorine) during outbreaks. Although norovirus is relatively resistant to alcohol, there is no evidence that alcohol-based hand hygiene products are not effective for hand decontamination. Aerosolization as a mode of infection may occur, and those who are engaged in cleaning heavily infected areas of vomitus and feces may benefit by wearing masks (12, 125) .
Parasites
Much of the developing world has a relatively high endemic burden of parasitic and bacterial enteric pathogens, unlike developed countries. It is possible that parasites, such as Giardia lamblia and Cryptosporidium, may be underestimated causes of hospital-associated infection in developing countries due to their low infectious doses, but the prevalence of these diseases is unclear. Hospitalassociated parasitic gastrointestinal infections in the United States are extremely rare. However, one must still maintain vigilance in the hospital for spatially related cases, during large community outbreaks of waterborne Cryptosporidium, or temporal increase in Cyclospora cases in association with contaminated water or food.
Cryptosporidium. Cryptosporidium species are protozoan parasites with a worldwide distribution, and infection occurs after ingestion of the oocyst. Increase in cases typically occurs in warm, moist months with peaks from July through September in temperate-zone countries (126) . It is transmitted by fecaloral route, and large outbreaks have occurred due to surface water contamination in the United States (127) . It is estimated that 300,000 people are affected each year in the United States in the absence of an outbreak (112) . Cryptosporidiosis is particularly problematic in patients with HIV-acquired immune deficiency syndrome, in immunosuppressed transplant patients, and in children with primary immunodeficiencies (128 -130) . Hospital-associated infection has been reported in healthcare workers spatially related to patients (131, 132) . However, there seems to be low transmission risk, even between those with HIVacquired immune deficiency syndrome, with standard precautions of gloving and hand washing (132) .
The development of symptoms is variable and seems to be strain dependent, ranging from mild and self-limited to more severe (133) . In immunocompetent persons, cryptosporidiosis is less likely to cause vomiting than other causes of gastroenteritis, and relapses may follow a diarrhea-free period of days to weeks (134) . Cryptosporidiosis in HIV patients has decreased in incidence due to improved highly active retroviral therapy (135) . However, chronic diarrhea is characterized by frequent, foul-smelling bulky stools with development of malabsorption and malnutrition, or less frequently, voluminous watery diarrhea.
The sensitivity and specificity for acidfast staining of the oocyst in stool are poor, requiring Ͼ500,000 oocysts/mL, and oocysts can be confused with Isospora and Cyclospora (136, 137) . Although antigen detection immunoassays have specificity and sensitivities from 66% to 100%, there have been pseudo-outbreaks due to falsepositive results (138, 139) . Nested polymerase chain reaction has been described for detection of Cryptosporidium in stool (140) .
Patients with bowel incontinence or in diapers should be placed in contact precautions for the duration of their illness. Cryptosporidium is difficult to eradicate from hard surfaces. Oocysts can remain infectious for 6 months if kept moist and are extremely resistant to chlorination (2-hr exposure to 5% bleach), especially in the presence of fecal material (141, 142) . In addition, oocysts are also resistant to various concentrations of alcohols, phenol, iodophors, and quaternary ammonium com-pounds, but a 1000-fold decrease in infectivity occurs with a 4-min exposure to 6% to 7% hydrogen peroxide (143) . Despite the resistance of Cryptosporidium oocysts to multiple agents, standard hospital disinfectants can be used in the absence of an institutional outbreak.
Prevention and Control Measures
The National Academy of Engineering and the Institute of Medicine recommended using systems engineering approaches for improving the healthcare delivery system (144, 145) . This recommendation was based on observations that the current care delivery system is not designed to support care of complex patients, requiring multiple providers and services (149). The rapid increase in C. difficile hospital-associated infection and disease severity are examples of this. Systems engineering encompasses coordination, synchronization, and integration of complex systems of personnel, information, and financial resources.
In the ICU, specific systems should be in place to decrease the occurrence of human error in recognizing, treating, and controlling hospital-associated intestinal infections. Once diarrhea has been recognized, clearly delineated protocols that pertain to identifying the cause and reducing the risk of transmission of infectious agents to others should be implemented. These protocols involve the infection prevention and control department, nurses, physicians, support staff, visitors, and housekeeping staff. For C. difficile, pharmacy should also be included in the development of treatment and prevention protocols. Protocols must be formatted so they are easily accessible to clinical staff caring for patients and easy to identify the policies for specific syndromes and/or pathogens.
Recognition that patient has diarrhea or ileus
The first step to preventing the spread of an infectious cause of gastroenteritis is recognizing which patients have compatible clinical syndromes and promptly initiating diagnostic, treatment, and prevention protocols. Usually, the nursing staff in the ICU is the first to become aware that the patient's stooling pattern has deviated from normal. All patients with diarrhea that might be due to a transmissible agent should immediately be placed on contact precautions if they have bowel incontinence or are diapered. Because C. difficile is overwhelmingly the most common cause of infectious diarrhea in adult hospitalized patients, many healthcare facilities allow nurses to send stool for C. difficile testing by means of a standing order or a telephone order if there is concern for CDI. These order sets can be altered as needed for ongoing outbreaks due to other pathogens or other patient populations (i.e., pediatric). Results of diagnostic testing can then be used to guide additional prevention efforts and treatment.
Verbal and electronic communication that a pathogen has been found
Appropriate clinical personnel must be alerted immediately when an epidemiologically important enteric pathogen is identified. At a minimum, ICU staff caring for the patient, the treating intensivist, and the infection prevention and control department should be notified. These steps allow adjustment of treatment if needed, initiation of appropriate prevention measures (if not already done), and surveillance initiation by infection prevention and control personnel. The method by which these personnel are notified will depend on where the test is performed and existing infrastructure. Methods in which the alert may not be noted immediately (e.g., fax) should not be the sole method for reporting the alert.
Isolation precautions and hand hygiene
Methods facilitating adherence to proper infection control procedures and policies must be in place. If any measures beyond standard/universal precautions are necessary, place clearly visible signs to indicate what precautions are necessary outside the patient's room. For contact precautions, dedicated patient care equipment is placed in the room, and gowns and gloves are made readily available to all people before entering the room. Assign responsibility for monitoring the availability and restocking of supplies to specific healthcare personnel. Alcohol-based hand hygiene products should be easily accessible.
Environmental cleaning
Cleaning responsibilities and protocols are to be clearly defined for the particular pathogen. For example, it is uncommon for housekeepers to be responsible for cleaning medical equipment inpatient rooms, such as ventilators. Specific ICU staff must be assigned to clean the ventilators and any other equipment for which housekeeping staff are not responsible. Environmental disinfectants are often purchased in concentrated form and diluted before use. Systems need to be in place to ensure cleaning agents that are not typically used for daily cleaning are mixed in the proper proportions and applied as directed if they are needed for specific pathogens.
Conclusion
The three most common hospitalassociated enteric pathogens in the United States, C. difficile, norovirus, and rotavirus, cause significant morbidity and economic losses due to unit closures and furloughing of staff. Lags in diagnosis and treatment can be devastating to the already fragile ICU patient. When considering a causative pathogen, it is important to consider not only symptomatology but also patient risk factors, spatial/temporality of cases in the rest of the hospital, and current outbreaks in the community.
Correct recognition of etiology plus prompt implementation of preventive measures is critical. This can be encouraged by designing systems that facilitate indicated isolation precautions, healthcare worker compliance with the precautions, and environmental decontamination. 
